Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001398344-25-020925
Filing Date
2025-11-14
Accepted
2025-11-14 09:31:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 14384
  Complete submission text file 0001398344-25-020925.txt   15831
Mailing Address 712 FIFTH AVE 45TH FL NEW YORK NY 10019
Business Address
FELDMAN STUART (Filed by) CIK: 0001237237 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Subject) CIK: 0001823239 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92094 | Film No.: 251481844
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)